Stock listing
OSTX Stock Price, News, Filings & Events — Os Therapies Incorporated
Selected listing: OSTX · AMEX · USD · US
This page tracks Os Therapies Incorporated's OSTX:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OSTX:AMEX. OSTX:AMEX is the stock-level entry point for investors researching Os Therapies Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Os Therapies Incorporated (OSTX) is a public company based in the United States, with a market capitalization of approximately $68.1 million. The company focuses on developing innovative therapies and solutions in its field. Investors can find relevant information about its operations and performance on its public company page.
- Ticker
- OSTX:AMEX
- Asset type
- Stock
- Market cap
- $78.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- AMEX
- Currency
- USD
Os Therapies Incorporated OSTX:AMEX stock context
This page tracks Os Therapies Incorporated's OSTX:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OSTX:AMEX. OSTX:AMEX is the stock-level entry point for investors researching Os Therapies Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Os Therapies Incorporated (OSTX) is a public company based in the United States, with a market capitalization of approximately $68.1 million. The company focuses on developing innovative therapies and solutions in its field. Investors can find relevant information about its operations and performance on its public company page.
Latest news from Os Therapies Incorporated
OS Therapies Achieves Statistically Significant Benefit for OST-HER2-Treated Patients in Interim 3-Year Overall Survival Analysis of Phas...
September 8, 2026
OS Therapies Provides OST-HER2 Metastatic Osteosarcoma Program Update and Announces Upcoming Conference Attendance
September 2, 2026
OS Therapies Reports Second Quarter 2026 Financials and Provides Business and Regulatory Updates
August 17, 2026
OS Therapies Granted U.S. FDA Type C Statistical Methods Meeting to Review 2.5-Year Overall Survival Data for OST-HER2 in the Prevention ...
August 13, 2026
OS Therapies Accepts New FDA Meeting Request to Review Biomarker Data as Part of BEST Program
July 8, 2026
Research Os Therapies Incorporated
Os Therapies Incorporated investor report
Review AI stock analysis and investor report context for OSTX:AMEX.
Os Therapies Incorporated company profile
View the public company page for Os Therapies Incorporated on 6ix.
Os Therapies Incorporated news
Read company news and market updates connected to Os Therapies Incorporated.
Os Therapies Incorporated investor events
Find investor webinars, events, and replay context for Os Therapies Incorporated.